ϟ
DOI: 10.1038/nature12441
OpenAccess: Closed
This work is not Open Acccess. We may still have a PDF, if this is the case there will be a green box below.
Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers
Georgia Hatzivassiliou,Jacob R. Haling,Huifen Chen,Kyung Song,Steve Price,Robert A. Heald,Joanne F. M. Hewitt,Mark Zak,Ariana Peck,Christine Orr,Mark Merchant,Klaus P. Hoeflich,Jocelyn Chan,Shiuh-Ming Luoh,Daniel J. Anderson,Mary J. C. Ludlam,Christian Wiesmann,Mark Ultsch,Lori S. Friedman,Shiva Malek,Marcia Belvin
KRAS
MAPK/ERK pathway
MEK inhibitor
2013
Loading...
- MLA
- APA
- Chicago
- IEEE
- Harvard
- BibTeX
Cite this:
Generate Citation
“Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers” is a paper by Georgia Hatzivassiliou Jacob R. Haling Huifen Chen Kyung Song Steve Price Robert A. Heald Joanne F. M. Hewitt Mark Zak Ariana Peck Christine Orr Mark Merchant Klaus P. Hoeflich Jocelyn Chan Shiuh-Ming Luoh Daniel J. Anderson Mary J. C. Ludlam Christian Wiesmann Mark Ultsch Lori S. Friedman Shiva Malek Marcia Belvin published in 2013. It has an Open Access status of “closed”. You can read and download a PDF Full Text of this paper here.